Dr. Dennis Slamon's honor in precision medicine masks the crushing reality of high drug costs and access inequality in modern healthcare.
Digital health tools promise patient empowerment, but the real story behind this 'revolution' in **healthcare technology** is far more complex and corporate.
The hype around BBB-crossing antibody technology masks a brutal reality. Is this truly a breakthrough, or just another pharmaceutical mirage in the fight against neurodegeneration?
The convergence of healthcare and artificial intelligence isn't just hype; it's a seismic shift threatening incumbents. Discover the hidden winners in the new pharma landscape.
Forget the headlines. The real story behind global demand for Israeli technology reveals a hard geopolitical truth about strategic dependency and innovation.
The supposed AI leadership of North Carolina isn't about innovation; it's about cheap labor pipelines. Unpacking the real winners in this tech narrative.
Behind the glossy veneer of 'translating science' in Cystic Fibrosis, we dissect the hidden economic winners and the ethical cost of next-gen therapies.
Forget personalized medicine. The 'health and wellness' breakthroughs of 2025 reveal a hidden agenda: monetizing anxiety. We dissect the real winners.
The Greenland shark holds the secret to longevity, but the real story is the biotech gold rush this discovery triggers. Dive into the science.
Forget innovation hype. This $40 million defense technology program reveals who truly controls the national security spending narrative.
Forget dieting. A new study promises safer cell calorie burning, but the real story behind this metabolic breakthrough is the looming shadow of Big Pharma.
OPKO Health is at J.P. Morgan, but the real story isn't the conference; it's the silent battle for solvency in the volatile biotech sector.